Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Vaccines

Free Subscription 30.03.2026 1 BMJ 4 J Infect Dis 1 J Virol 1 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 1 Nat Med 1 Pediatr Infect Dis J 1 PLoS One 1 Proc Natl Acad Sci U S A 15 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. WISE J
   Covid vaccines are not linked to sudden death in healthy younger adults, study finds.
   BMJ. 2026;392:s589.
   PubMed        
   
   

   
   J Infect Dis

2. CHEN WH, Beckett CG, Al-Ibrahim M, Datar R, et al
   Safety and Immunogenicity of a Trivalent Salmonella Conjugate Vaccine to S. Typhi, S. Typhimurium, and S. Enteritidis.
   J Infect Dis. 2026 Mar 26:jiag156. doi: 10.1093.
   PubMed         Abstract available
   
   
3. KACHIKIS A, Frivold C, Pike M, Reed JC, et al
   Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination.
   J Infect Dis. 2026 Mar 26:jiag111. doi: 10.1093.
   PubMed         Abstract available
   
   
4. JIHAD T, Chi XS, He Z, Lee K, et al
   Establishment of a Neonatal Natural Transmission Model for CMV Vaccine Development.
   J Infect Dis. 2026 Mar 23:jiag170. doi: 10.1093.
   PubMed         Abstract available
   
   
5. PERSSON C
   Comment on: "Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine".
   J Infect Dis. 2026 Mar 20:jiag180. doi: 10.1093.
   PubMed        
   
   

   
   J Virol

6. WANG J, Chang J, Jiang Z, Deng H, et al
   An oral rotavirus-vectored vaccine confers protection against Clostridium perfringens and rotavirus.
   J Virol. 2026 Mar 26:e0017826. doi: 10.1128/jvi.00178.
   PubMed         Abstract available
   
   

   
   MMWR Morb Mortal Wkly Rep

7. HILL HA, Yankey D, Elam-Evans LD, Mu Y, et al
   Vaccination Coverage by Age 24 Months Among Children Born in 2021 and 2022 - National Immunization Survey-Child, United States, 2022-2024.
   MMWR Morb Mortal Wkly Rep. 2026;75:146-155.
   PubMed         Abstract available
   
   

   
   N Engl J Med

8. OPEL DJ, O'Leary ST
   Communicating about Vaccines in a Politically Contentious Climate.
   N Engl J Med. 2026;394:1145-1147.
   PubMed        
   
   

   
   Nat Med

9. HAANEN JB, Schumacher TNM, Kagan JC, Fritsch EF, et al
   Publisher Correction: Clinical development of cancer vaccines.
   Nat Med. 2026 Mar 26. doi: 10.1038/s41591-026-04361.
   PubMed        
   
   

   
   Pediatr Infect Dis J

10. DE BOCK M, Marbaix S, Goovaerts H, Debieve F, et al
    Health and Economic Impact of Seasonal Maternal Vaccination With Bivalent Respiratory Syncytial Virus Prefusion F Vaccine in Belgium.
    Pediatr Infect Dis J. 2026 Apr 7. doi: 10.1097/INF.0000000000005226.
    PubMed         Abstract available
    
    

    
    PLoS One

11. YAN K, Yang G, Yan L, Wu L, et al
    Global trends and forecasts of cervical cancer and a real-world safety assessment of human papillomavirus vaccines in women: A systematic analysis of the Global Burden of Disease study 2021 and the Vaccine Adverse Event Reporting System database.
    PLoS One. 2026;21:e0345286.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

12. 
    Correction for Te et al., Broad beta-CoV immunity and transmission blockade by a single-dose live-attenuated vaccine with atypical codon usage.
    Proc Natl Acad Sci U S A. 2026;123:e2607878123.
    PubMed        
    
    

    
    Vaccine

13. JAMES E, Christie S, Boye B, Githieya D, et al
    How to leverage social media to build confidence in COVID-19 vaccines: findings and lessons learned from nationwide campaigns in four countries.
    Vaccine. 2026;79:128475.
    PubMed         Abstract available
    
    
14. FRAWLEY JE, Hutchens J, Wiley K, Mahimbo A, et al
    Uptake of Commonwealth funded influenza vaccines for Australian children aged 6-months to <5 years during the COVID-19 pandemic.
    Vaccine. 2026;79:128514.
    PubMed         Abstract available
    
    
15. OOI JSG, Hamis NZ, Tan HC, Yee JX, et al
    Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans.
    Vaccine. 2026;79:128510.
    PubMed         Abstract available
    
    
16. ZHONG L, Tao L, Zhai Z, Liao L, et al
    The stability landscape of mRNA vaccines: challenges and mitigation strategies.
    Vaccine. 2026;79:128515.
    PubMed         Abstract available
    
    
17. VARGAS-ZAMBRANO JC, Arnaud M, Antunes A, Karzazi K, et al
    Evaluating pertussis vaccine effectiveness in children under 5 years of age born in France between 2013 and 2019.
    Vaccine. 2026;79:128472.
    PubMed         Abstract available
    
    
18. SIMON R, Arrogante A, Nogales-Merida S, Diaz-Rosales P, et al
    DNA vaccination against viral hemorrhagic septicemia virus (VHSV) affects the capacity of kidney leukocytes to respond to a posterior viral encounter.
    Vaccine. 2026;79:128512.
    PubMed         Abstract available
    
    
19. MALDEN DE, Ackerson BK, Gee J, Peryer MA, et al
    Self-reported reactogenicity of RSV vaccines among older adults: a post-licensure study within a large integrated healthcare system in Southern California.
    Vaccine. 2026;79:128493.
    PubMed         Abstract available
    
    
20. FANTIN R, Das S, Loria V, Calderon A, et al
    Hybrid immunity provides stronger protection against SARS-CoV-2 infection than vaccination alone: Evidence from a population-based active monitoring study.
    Vaccine. 2026;79:128506.
    PubMed         Abstract available
    
    
21. DENG L, Barton B, Choi P, Clarke L, et al
    Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.
    Vaccine. 2026;79:128501.
    PubMed         Abstract available
    
    
22. HUANG A, Li J, Tang L, Xu X, et al
    Cost-effectiveness of hepatitis A vaccination for adults in China: A decision tree Markov model study.
    Vaccine. 2026;79:128509.
    PubMed         Abstract available
    
    
23. VONDELING GT, Croda J, Jelinek T, Kassianos G, et al
    Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ).
    Vaccine. 2026;79:128491.
    PubMed         Abstract available
    
    
24. BRIGGS K, Gingerich MC, Gingerich A, Johnson SK, et al
    Intranasal PIV5-vectored SARS-COV-2 KP.2 vaccine protects against homologous and heterologous challenge in mice and hamsters.
    Vaccine. 2026;79:128490.
    PubMed         Abstract available
    
    
25. QUACH HQ, Ratishvili T, Haralambieva IH, Ovsyannikova IG, et al
    Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine.
    Vaccine. 2026;79:128480.
    PubMed         Abstract available
    
    
26. ROSSO A, Riccio M, Renzi E, Patania F, et al
    The role of school-based health education in promoting childhood and adolescent vaccination: A systematic review and Meta-analysis.
    Vaccine. 2026;79:128479.
    PubMed         Abstract available
    
    
27. SILVA LL, Lopes VDS, da Silva DCB, Nemer CRB, et al
    Global overview of vaccine trust: Evidence from a scoping review.
    Vaccine. 2026;79:128482.
    PubMed         Abstract available
    
    

    
    Virology

28. MORALES RUIZ S, Wang Z, Miura T, Shida H, et al
    Potent protective ability of vaccinia virus LC16 strains lacking the B5R gene.
    Virology. 2026;619:110888.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum